Faruqi and Faruqui, LLP Logo
Share this page

In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., No. 13-cv-2445 (E.D. Pa.)


In the Suboxone case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Reckitt Benckiser’s opioid addiction drug, Suboxone.  The proposed class alleges that Reckitt took several actions to suppress competition from generic versions of Suboxone, including reformulating Suboxone into a film (for which generic versions of Suboxone tablets could not be substituted by pharmacists), sabotaging efforts to create a joint REMS program, and filing a baseless citizens petition.  Faruqi & Faruqi was appointed co-lead counsel by the Court.

Contact Counsel

Peter Kohn
Joseph T. Lukens

Faruqi & Faruqi, LLP
1617 JFK Boulevard, Suite 1550
Philadelphia, PA 19103
Tel: (215) 277-5770


Case Details


  • 03/05/2013

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.